In an ongoing antitrust litigation against pharmaceutical giant Pfizer regarding the cholesterol medication Lipitor, a class of buyers is awaiting approval from a New Jersey federal judge for their request of $31 million in fees. This development follows an agreement made last February where Pfizer consented to a $93 million settlement.
The attorneys representing the class of buyers have been vigorously drawing attention to the scale of the settled amount during this litigation process. For further information, you are encouraged to read the coverage provided by Law360.
Antitrust lawsuits, especially those involving large sums and major corporations like Pfizer, often arouse significant Legal industry attention and discussion. The necessity and proportionality of the requested attorney’s fees relative to the settlement amount will undoubtedly form part of these discussions among legal professionals.